Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2025-12-24 @ 11:11 PM
NCT ID:
NCT02813369
Eligibility Criteria:
Inclusion Criteria:
1\. Patient receives a new prescription for naloxegol or a non-PAMORA laxative. (Note: Only non-PAMORA laxatives that are approved/marketed in the European Union at the time naloxegol is authorized are permitted.)
Exclusion Criteria:
1. Patients \<18 years of age on cohort entry date
2. Patients with \<1 year of continuous data available prior to cohort entry date
3. Patients without exposure to current regular opioid use defined by \>30 days of opioid exposure within the 180 days prior to and inclusive of the cohort entry date
4. Patients with evidence of a cancer indicator (diagnosis or treatment) prior to cohort entry date
5. Exposure to PAMORA laxatives, alvimopan, methylnaltrexone, or naloxone + opioid combination (including fixed-dose combinations) prior to cohort entry date
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02813369
Study Brief:
Protocol Section:
NCT02813369